Precision medicine in oncology

Wednesday 23 November 2022 - 2pm to 3:30pm

Early phase cancer clinical trials have changed significantly over the last decade, and the opportunity for patients to participate in research has never been greater. The Experimental Cancer Medicine Team (ECMT) at The Christie are at the frontier of novel treatments, including cellular therapies.

The ECMT invite you to learn about the types of molecular profiling available for cancer patients in Greater Manchester, interpreting and understanding genetic results as well as how molecular profiling is becoming available to all patients with cancer.

Healthcare professionals with research experience working in Greater Manchester, and healthcare professionals in Greater Manchester interested in early phase research and who seek to improve equality, diversity, and inclusion.

  • What types of molecular profiling are available routinely for cancer patients?
  • Understanding and interpreting genomic results
  • State of the art precision medicine trials in the UK

Sign up to our education events mailing list to be kept up to date with this and future events

Last updated: September 2022

© 2022 The Christie NHS Foundation Trust